649 related articles for article (PubMed ID: 19438995)
1. Low-dose UVA1 phototherapy for proximal and acral scleroderma in systemic sclerosis.
Rose RF; Turner D; Goodfield MJ; Goulden V
Photodermatol Photoimmunol Photomed; 2009 Jun; 25(3):153-5. PubMed ID: 19438995
[TBL] [Abstract][Full Text] [Related]
2. Successful ultraviolet A1 phototherapy in the treatment of localized scleroderma: a retrospective and prospective study.
Andres C; Kollmar A; Mempel M; Hein R; Ring J; Eberlein B
Br J Dermatol; 2010 Feb; 162(2):445-7. PubMed ID: 19785603
[TBL] [Abstract][Full Text] [Related]
3. Ultraviolet A1 (340-400 nm) phototherapy for scleroderma in systemic sclerosis.
Morita A; Kobayashi K; Isomura I; Tsuji T; Krutmann J
J Am Acad Dermatol; 2000 Oct; 43(4):670-4. PubMed ID: 11004624
[TBL] [Abstract][Full Text] [Related]
4. Ultraviolet A1 phototherapy for treatment of acrosclerosis in systemic sclerosis: controlled study with half-side comparison analysis.
Durand F; Staumont D; Bonnevalle A; Hachulla E; Hatron PY; Thomas P
Photodermatol Photoimmunol Photomed; 2007 Dec; 23(6):215-21. PubMed ID: 17986056
[TBL] [Abstract][Full Text] [Related]
5. A randomized controlled study of low-dose UVA1, medium-dose UVA1, and narrowband UVB phototherapy in the treatment of localized scleroderma.
Kreuter A; Hyun J; Stücker M; Sommer A; Altmeyer P; Gambichler T
J Am Acad Dermatol; 2006 Mar; 54(3):440-7. PubMed ID: 16488295
[TBL] [Abstract][Full Text] [Related]
6. Medium dose long-wavelength ultraviolet A (UVA1) phototherapy for the treatment of acute and chronic graft-versus-host disease of the skin.
Wetzig T; Sticherling M; Simon JC; Hegenbart U; Niederwieser D; Al-Ali HK
Bone Marrow Transplant; 2005 Mar; 35(5):515-9. PubMed ID: 15665847
[TBL] [Abstract][Full Text] [Related]
7. Medium-dose UVA1 phototherapy in localized scleroderma and its effect in CD34-positive dendritic cells.
Camacho NR; Sánchez JE; Martin RF; González JR; Sánchez JL
J Am Acad Dermatol; 2001 Nov; 45(5):697-9. PubMed ID: 11606918
[TBL] [Abstract][Full Text] [Related]
8. Ultraviolet A1 phototherapy decreases inhibitory SMAD7 gene expression in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Tomi NS; Breuckmann F; Altmeyer P; Gambichler T
Arch Dermatol Res; 2006 Nov; 298(6):265-72. PubMed ID: 17009056
[TBL] [Abstract][Full Text] [Related]
9. Low-dose UVA₁ phototherapy for scleroderma: what benefit can we expect?
Pereira N; Santiago F; Oliveira H; Figueiredo A
J Eur Acad Dermatol Venereol; 2012 May; 26(5):619-26. PubMed ID: 21635565
[TBL] [Abstract][Full Text] [Related]
10. Ultraviolet A1-induced downregulation of human beta-defensins and interleukin-6 and interleukin-8 correlates with clinical improvement in localized scleroderma.
Kreuter A; Hyun J; Skrygan M; Sommer A; Bastian A; Altmeyer P; Gambichler T
Br J Dermatol; 2006 Sep; 155(3):600-7. PubMed ID: 16911288
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of microstomia with UVA1 phototherapy in systemic sclerosis.
Tewari A; Garibaldinos T; Lai-Cheong J; Groves R; Sarkany R; Branislav Novakovic L
Photodermatol Photoimmunol Photomed; 2011 Apr; 27(2):113-4. PubMed ID: 21392116
[No Abstract] [Full Text] [Related]
12. Ultraviolet A1 phototherapy beyond morphea: experience in 83 patients.
Connolly KL; Griffith JL; McEvoy M; Lim HW
Photodermatol Photoimmunol Photomed; 2015 Nov; 31(6):289-95. PubMed ID: 26052743
[TBL] [Abstract][Full Text] [Related]
13. Different low doses of broad-band UVA in the treatment of morphea and systemic sclerosis.
El-Mofty M; Mostafa W; El-Darouty M; Bosseila M; Nada H; Yousef R; Esmat S; El-Lawindy M; Assaf M; El-Enani G
Photodermatol Photoimmunol Photomed; 2004 Jun; 20(3):148-56. PubMed ID: 15144393
[TBL] [Abstract][Full Text] [Related]
14. [Ultraviolet-A1 (UVA1) phototherapy in lichen sclerosus et atrophicus].
Kreuter A; von Kobyletzki G; Happe M; Herde M; Breuckmann F; Stücker M; Altmeyer P
Hautarzt; 2001 Oct; 52(10):878-81. PubMed ID: 17690817
[TBL] [Abstract][Full Text] [Related]
15. UVA1 phototherapy is effective in darker skin: a review of 101 patients of Fitzpatrick skin types I-V.
Jacobe HT; Cayce R; Nguyen J
Br J Dermatol; 2008 Sep; 159(3):691-6. PubMed ID: 18544076
[TBL] [Abstract][Full Text] [Related]
16. Effectiveness of medium-dose ultraviolet A1 phototherapy in localized scleroderma.
Su O; Onsun N; Onay HK; Erdemoglu Y; Ozkaya DB; Cebeci F; Somay A
Int J Dermatol; 2011 Aug; 50(8):1006-13. PubMed ID: 21781079
[TBL] [Abstract][Full Text] [Related]
17. Localized and systemic scleroderma.
Hawk A; English JC
Semin Cutan Med Surg; 2001 Mar; 20(1):27-37. PubMed ID: 11308134
[TBL] [Abstract][Full Text] [Related]
18. Period of remission after treatment with UVA-1 in sclerodermic skin diseases.
Kroft EB; van de Kerkhof PC; Gerritsen MJ; de Jong EM
J Eur Acad Dermatol Venereol; 2008 Jul; 22(7):839-44. PubMed ID: 18452527
[TBL] [Abstract][Full Text] [Related]
19. Granulomatous slack skin responds to UVA1 phototherapy.
Oberholzer PA; Cozzio A; Dummer R; French LE; Hofbauer GF
Dermatology; 2009; 219(3):268-71. PubMed ID: 19546523
[TBL] [Abstract][Full Text] [Related]
20. Low-dose UVA1 phototherapy in systemic sclerosis: effects on acrosclerosis.
Kreuter A; Breuckmann F; Uhle A; Brockmeyer N; Von Kobyletzki G; Freitag M; Stuecker M; Hoffmann K; Gambichler T; Altmeyer P
J Am Acad Dermatol; 2004 May; 50(5):740-7. PubMed ID: 15097958
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
